Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CJM112 |
Synonyms | |
Therapy Description |
CJM112 is a human anti-Interleukin (IL)-17 antibody that inhibits IL-17 downstream signaling (ECTRIMS Oct 8, 2015, Abstract: P655). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CJM112 | CJM-112|CJM 112 | CJM112 is a human anti-Interleukin (IL)-17 antibody that inhibits IL-17 downstream signaling (ECTRIMS Oct 8, 2015, Abstract: P655). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|